A5065977118- Ovarian cancer diagnosis and treatment
- Endometrial and Cervical Cancer Treatments
- BRCA gene mutations in cancer
- Intraperitoneal and Appendiceal Malignancies
- Uterine Myomas and Treatments
- Surgical Simulation and Training
- Cervical Cancer and HPV Research
- Cancer Genomics and Diagnostics
- Innovations in Medical Education
- Endometriosis Research and Treatment
- Anatomy and Medical Technology
- Renal cell carcinoma treatment
- Economic and Financial Impacts of Cancer
- Cancer survivorship and care
- Cardiac, Anesthesia and Surgical Outcomes
- Diversity and Career in Medicine
- Lymphoma Diagnosis and Treatment
- Cancer-related molecular mechanisms research
- Cancer Research and Treatments
- Ovarian function and disorders
- Global Cancer Incidence and Screening
- Gynecological conditions and treatments
- Colorectal and Anal Carcinomas
- Palliative Care and End-of-Life Issues
- Reproductive Biology and Fertility
University of Washington
2016-2025
University of Washington Medical Center
2013-2023
Seattle University
1996-2022
Memorial Sloan Kettering Cancer Center
2012-2021
Lehigh Valley Health Network
2021
Levine Cancer Institute
2021
Woman's Cancer Foundation
1996-2018
Alaska Women's Cancer Care
2018
Seattle Cancer Care Alliance
2008-2017
University of Toronto
2016
Purpose This randomized, multicenter, blinded, placebo-controlled phase III trial tested the efficacy and safety of bevacizumab (BV) with gemcitabine carboplatin (GC) compared GC in platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer (ROC). Patients Methods ROC (recurrence ≥ 6 months after front-line platinum-based therapy) measurable disease were randomly assigned to plus either BV placebo (PL) for six 10 cycles. PL, respectively, was then continued until...
BACKGROUND Ovarian carcinoma often is called the "silent killer" because disease usually not detected until an advanced stage. The authors' goal was to evaluate preoperative symptoms and factors that may contribute delayed diagnosis for women with ovarian carcinoma. METHODS A two-page survey distributed 1500 who subscribe CONVERSATIONS!, a newsletter about Because could be copied given other patients, 1725 surveys were returned from in 46 states 4 Canadian provinces. RESULTS median age of...
Women with ovarian cancer frequently report symptoms prior to diagnosis, but distinguishing these from those that normally occur in women remains problematic.To compare the frequency, severity, and duration of between presenting primary care clinics.A prospective case-control study who visited 2 clinics (N = 1709) completed an anonymous survey experienced over past year (July 2001-January 2002). Severity was rated on a 5-point scale, recorded, frequency indicated as number episodes per...
Currently, screening for ovarian cancer is not recommended the general population. Targeting women with specific symptoms has been evaluated only recently, because it was believed that had limited specificity.A case-control study of 149 cancer, including 255 who were in a program and 233 referred pelvic/abdominal ultrasound, conducted by inviting to complete survey symptoms. Patients divided randomly into an exploratory group confirmatory group. Symptom types, frequency, severity, duration...
Abstract BACKGROUND. Providing appropriate surgical treatment for women with ovarian cancer is one of the most effective ways to improve outcomes. In this study, authors identified factors that were associated a measure comprehensive surgery, so interventions may be targeted appropriately care. METHODS. Using Healthcare Cost and Utilization Project hospital discharge data from 1999 2002 9 states, 10,432 admissions who had an International Classification Disease, 9th Revision (ICD‐9) primary...
Objective: To develop an objective structured assessment for evaluating surgical skills of obstetrics and gynecology residents to evaluate the reliability validity assessment. Methods: A seven-station, objective, technical was administered 24 residents. The test included laparoscopic procedures (port placement, salpingostomy, suturing, vessel ligation) open abdominal (hypogastric ligation, repair enterotomy, salpingo-oophorectomy.) All tasks were done on pigs. Residents timed assessed at...
Ovarian cancer is the second most common gynecologic malignancy in US and—because more than 70% of women affected are diagnosed with advanced-stage disease—the deadliest. Contrary to what might be expected, screening has not lessened mortality even high-risk populations. The idea targeting having specific symptoms screened relatively recent because general belief that have limited specificity. authors undertook a case-control study 149 ovarian cancer. An exploratory group served estimate...